ICICI Securities has released its long-term outlook for the Nifty, forecasting a statistical range between 24,200 and

29,200 by calendar year 2026. The firm suggests that the 24,200 level has acted as a reliable support during major

corrections since the COVID-19 pandemic.

Historically, strong market rallies have reached the upper statistical band, leading ICICI Securities to project a

potential upside target of 29,500 if bullish momentum continues through 2026. Based on this analysis, ICICI Securities

has identified its top five stock recommendations for the next 12 months, offering a potential upside of up to 26%.

**Top Stock Picks**

* **Bank of India:** ICICI Securities has set a target price of Rs 180 for Bank of India shares. They recommend buying

the stock in the range of Rs 132 to Rs 140, with a stop loss at Rs 115. This indicates a potential upside of 25.9% over

the next year.

* **Marico Ltd:** The brokerage anticipates Marico Ltd's stock price to reach Rs 880. Investors are advised to buy

between Rs 710 and Rs 740, with a stop loss at Rs 638. This reflects a projected upside of 19%, driven by consistent

performance in the FMCG sector and improved profit margins.

* **Ultratech:** ICICI Securities has a target price of Rs 14,500 for the cement giant Ultratech. The recommended buying

range is between Rs 11,200 and Rs 11,700, with a stop loss at Rs 9,970. This suggests a potential upside of 26% over the

next 12 months.

* **TCS:** ICICI Securities suggests accumulating TCS shares between Rs 3,120 and Rs 3,220, with a stop loss at Rs

2,840. With a 12-month target price of Rs 3,775, the IT company offers a potential return of 14.8%, fueled by

anticipated growth in technology spending.

* **Sun Pharma:** The final pick is Sun Pharma, with a target price of Rs 2,180. The recommended buying range is Rs

1,750 to Rs 1,790, with a stop loss at Rs 1,540. This setup indicates a potential upside of 25%, supported by strong

performance in both domestic and export markets.

*Disclaimer: The recommendations, suggestions, views, and opinions provided by experts are their own and do not reflect

the views of The Economic Times.*